EP0166476A2 - Inhaliergerät mit einem Aerosolgenerator - Google Patents

Inhaliergerät mit einem Aerosolgenerator Download PDF

Info

Publication number
EP0166476A2
EP0166476A2 EP85200830A EP85200830A EP0166476A2 EP 0166476 A2 EP0166476 A2 EP 0166476A2 EP 85200830 A EP85200830 A EP 85200830A EP 85200830 A EP85200830 A EP 85200830A EP 0166476 A2 EP0166476 A2 EP 0166476A2
Authority
EP
European Patent Office
Prior art keywords
aerosol
inhalator
nebulizer
generator
drying chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP85200830A
Other languages
English (en)
French (fr)
Other versions
EP0166476A3 (en
EP0166476B1 (de
Inventor
Adrianus Plomp
Rudolf Barend Jan De Jong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Priority to AT85200830T priority Critical patent/ATE42685T1/de
Publication of EP0166476A2 publication Critical patent/EP0166476A2/de
Publication of EP0166476A3 publication Critical patent/EP0166476A3/en
Application granted granted Critical
Publication of EP0166476B1 publication Critical patent/EP0166476B1/de
Expired legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
    • A61M15/0016—Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0018—Details of inhalators; Constructional features thereof with exhalation check valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/20—Valves specially adapted to medical respiratory devices
    • A61M16/208—Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers

Definitions

  • the invention relates to an aerosol generator-inhalator adapted to bring liquid pharmaceutical and diagnostic compositions into a condition suitable for inhalation.
  • a device also referred to as an atomiser, nebuliser or inhalator in the technical literature, serves to convert a liquid composition into an aerosol form which is then inhaled by a patient.
  • the liquid composition is a radioactive diagnostic
  • the resulting radioactive aerosol as described in United States Patent Specification 4,094,317, may be used, after inhaling by the patient, for lung scintigraphy or lung ventilation studies.
  • the device described in the said Patent Specification comprises a conventional ultrasonic aerosol generator.
  • the invention relates more in particular to an aerosol generator-inhalator of the kind mentioned in the opening paragraph, comprising in a mutually sealing connecting a nebulizer and means suitable for inhaling the aerosol.
  • Every known aerosol generator has for its disadvantage that during use the yield of inhalable aerosol is small with respect to the quantity of composition presented for atomising.
  • the actual nebulizer produces an aerosol having a considerable spreading in particle size.
  • the larger particles will usually not reach the bronchial tubes of the patient but on the way will deposit on the wall of the generator-inhalator system.
  • An aerosol generator having an evaporation chamber is known from Swedish Patent Application 81-556.
  • the liquid evaporates from the atomised droplets by heating.
  • a dry aerosol in an oversaturated vapour is formed.
  • the dry aerosol particles then may serve as condensation nuclei for the vapour, so that the aerosol particles will regain their original size, so will have an equally large diameter as immediately after atomisation.
  • the risk of deposition on the walls of the generator system is great and the particles deposit is the respiratory system more quickly. Therefore such a device is not suitable for the object of the present invention.
  • an aerosol generator-inhalator in which, according to the invention, the generator-inhalator in addition comprises an aerosol-drying chamber positioned between nebulizer and inhalation means, and a member for supplying drying air, and that a baffle or a wall serving as a baffle toward the aerosol-drying chamber is absent in the nebulizer, so that the atomised liquid can spray directly into the aerosol-drying chamber when the generator is used.
  • the aerosol generator-inhalator according to the invention is particularly suitable for bringing very short-living radioisotopes, such as gold-195m, into a condition suitable for inhalation
  • the device is certainly not restricted thereto.
  • an aerosol-drying chamber presents the great advantage that the medicament or diagnostic brought in an aerosol form, on its way does not deposit or deposits hardly on the wall of the generator-inhalator system, but substantially entirely remains available for inhalation.
  • a special feature of the invention is the possibility to employ a non aqueous carrier fluid as carrier substance for the pharmaceutically active substance to be nebulised.
  • a living organism will not tolerate in- ' halation of aerosols of such non-aqueous fluids because these aerosols have a strongly irritant action on the respiratory system.
  • the nature of certain pharmaceuticals may require volatile organic solvents as carrier fluid.
  • An aerosol acceptable to the individual who inhales it will only be possible in case the concentration of the vapour of organic solvent in the inhaled air is kept low.
  • the design of the aerosol generator-inhalator of the present invention makes such possible because very small amounts of fluid may be nebulized with virtually 100% production of aerosol.
  • the aerosol drying chamber will allow the droplets of organic solvent to evaporate immediately thus giving raise to a dry aerosol of solid particles of very small dimensions.
  • the drying process of an aerosol involving an organic solvent will in general proceed so fast that within short distance from the nebulizer the solid dry particles already emerge, resulting in an aerosol which has very little tendency to adhere to internal surfaces of the generator-inhalator, with as consequence that a very high percentage of the nebulized pharmaceutical becomes available for inhalation.
  • the aerosol generator-inhalator according to the invention is preferably constructed in such a way that the nebulizer comprises at least one hypodermic needle-shaped supply member communicating with at least one liquid reservoir, the open end of the supply member or members being positioned close to the wing nozzle of an air supply, said wing nozzle facing the aerosol-drying chamber.
  • said nebulizer is constructed in such manner, that the open end of the liquid supply member or members is positioned at a short distance before the wing nozzle of the.hypodermic needle-shaped air supply, which is positioned at an angle of approximately 90 degrees relative to the liquid supply member or members.
  • the distance between the open end of the liquid supply member or members and the wing nozzle of the air supply can be varied at will to reach optimum results in atomizing liquids having different physical properties, e.g. viscosities.
  • said nebulizer is constructed in such manner, that the wing nozzle of the air supply is positioned around the open end of the hypodermic needle-shaped liquid supply member, so that the air is supplied to the liquid to be nebulized through a circumferential gap having an adjustable or fixed width. It has been shown, that this latter embodiment gives adequate results as to fast and complete atomization of the supplied liquid. If the circumferential gap has an adjustable width, this width can be attuned to the physical properties, e.g. the viscosity, of the liquid to be atomized.
  • the nebulizer of the aerosol generator-inhalator preferably is constructed so that the air supply is connected to a compressed air supply means, suitable to cause air to flow out of the wing nozzle at a pressure of 200 to 600 kPa in a quantity of 40 to 80 litres per minute per mm 2 of surface area of the wing nozzle of the air supply.
  • a compressed air supply means suitable to cause air to flow out of the wing nozzle at a pressure of 200 to 600 kPa in a quantity of 40 to 80 litres per minute per mm 2 of surface area of the wing nozzle of the air supply.
  • the generator is intended to atomise the above-mentioned gold-195m, it may be desirable to atomise approximately 0.5 ml of the gold--195m-containing liquid, i.e. 0.5 ml of eluate which can be obtained from an Hg/Au generator, in approximately 0.5 ° minute as completely as possible. This has proved possible indeed by means of the above-described aerosol generator according to the invention. Then the size of the generated liquid droplets is at most approximately 10 micrometers.
  • the volume of the aerosol-drying chamber should be sufficient so that the evaporation in the aerosol-drying chamber to which the liquid particle leaving the nebulizer are exposed, does not lead to the vapour saturation point being reached at which point condensation may occur.
  • the aerosol-drying chamber comprises drying air, while air withdrawn form the aerosol-drying chamber is replenished with likewise drying air through the nebulizer.
  • An improvement can be achieved by supplying extra air not only through the air inlet but also through a ring of holes around the air inlet; it has been found that the possibility of deposition of the particles on the walls can still be reduced hereby.
  • the diameter of the aerosol particles generated is considerably reduced, in the case of the above-mentioned atomised gold-195m eluate with approximately a factor of 3; after drying, the maximum diameter of the particles still is at most approx. 3 micrometers.
  • the particle size distribution of the dried aerosol has a geometrically average diameter of approximately 0.4 micrometer and a geometrical range factor of approximately 1.9. Such a particle size distribution is extremely suitable for penetration deep into the lungs, into the alveoli, upon inhaling, even though the particles on their way through the more centrally situated bronchial tubes, grow again by condensation of liquid.
  • the aerosol-drying chamber should preferably have a volume of at least sixty thousand times the volume of the liquid composition to be atomised; so in the case of a composition of 0.5 ml, the aerosol-drying chamber should preferably has a volume of at least 30 litres; these values are defined for room temperature.
  • the inhaled quantity of air is not the same for every patient. By supplying the average consumption of air during use of the aerosol generator-inhalator, considered over a longer period of time usually no pressure above or below atmospheric pressure will arise in the aerosol-drying chamber.
  • the aerosol-drying chamber is preferably manufactured from a flexible material, preferably a flexible plastic, for example, polyethylene.
  • the aerosol generator-inhalator furthermore comprises an inhalation means having a mouthpiece or face mask through which the patient can inhale the generated aerosol.
  • the inhalation means is preferably constructed so as to comprise a mouthpiece.
  • the inhalation means comprises a room divided into three chambers, the chambers respectively being provided with an inlet tube for the aerosol from the aerosol-drying chamber, a mouthpiece, and an outlet tube for expired and surplus air, which outlet may be connected to a filter, if so desired, each chamber within the housing further communicating with the two other chambers through valves.
  • the pressure at which the valve between the chamber communicating with the aerosol-drying chamber and the chamber communicating with the mouthpiece is opened should be adjusted very accurately.
  • the valve may not open automatically at a small pressure above atomospheric pressure in the aerosol-drying chamber.
  • a spring force from approximately 6 to approximately 10 mbar, against which the valve is opened upon inhaling, is particularly suitable for this purpose.
  • the spring force can be obtained, for example, by means of a coil spring which either in the chamber communicating with the aerosol-drying chamber of in the chamber connected to the ' mouthpiece, bears on the valve in an upright position and keeps it pressed on its valve seat in the closed condition.
  • the coil spring Upon inhaling, the coil spring is slightly extended in the former case or is slightly compressed in the latter case, so that the valve becomes detached from the valve seat and is opened to admit aerosol from the aerosol-drying chamber to the mouthpiece.
  • the inhalation means is preferably manufactured for the greater part from a form--retaining material which can readily be cleaned and sterilised.
  • the aerosol generator-inhalator serves to generate a radioactive aerosol
  • the expired air must be passed through a filter suitable for that purpose, so as to remove radioactive constituents from the expired air.
  • inhalation means is not restricted to the use in an aerosol generator-inhalator as descibred above, but also extends to the use in other aerosol generator-inhalators, for example, known aerosol generator-inhalators of the disposable type.
  • the aerosol generator-inhalator shown in Figure 1 comprises a nebulizer 10 which is composed of an inlet needle 12 connected to a liquid reservoir 11, an air inlet 13 connected, through a distributor 14, to a cylinder 15 with dry compressed air, an aerosol-drying chamber 16 having a volume of approximately 30 litres and comprising an inlet 17 with valve 31 for dry air (herewith the aerosol-drying chamber can be rinsed more quickly), an inlet tube 18 through which the formed aerosol can reach the inhalation means 19, and an outlet tube 21 for expired and surplus air, connected to a filter 20.
  • Extra dry air can be supplied at 32 through a ring of apertures around the air inlet.
  • the aerosol-drying chamber has the form of a cylinder closed at each end (length approximately 60 cm; diameter approximately 25 cm) the end walls of which are formed from circular plates of synthetic material having the necessary perforations, and the side wall consists of flexible polythene sheet.
  • the side wall is connected around the end walls so as to be air-tight.
  • the nebulizer will be described with reference to Figure 2.
  • the liquid supply needle and the air supply needle are again referenced 12 and 13, respectively.
  • the needle duct diameter of the liquid supply decreases stepwise to 0.23 mm (at a); the needle is flattened at its end.
  • the dimensions of the air inlet needle are the same as those of the liquid inlet needle.
  • Numeral 33 denotes a nipple for the connection to an inlet for extra air; the air can be admitted to the generator through a ring of apertures 34 around air inlet 13.
  • the needles are firmly connected in a nebulizer housing 22 and can be moved relatively to each other by means of adjusting screws 23 and 24.
  • FIG. 3 Another suitable embodiment of a nebulizer is schematically shown in cross-sectional view in Figure 3.
  • the liquid supply and the air supply are provided with reference numerals 35 and 36 respectively.
  • the liquid supply needle 37 extends axially within an outer sleeve 38 nearly to the aperture 39 in the end surface of the inwardly tapering part 40 of said sleeve.
  • the outer sleeve is provided with fastening means 41 on its outer side for attaching the sleeve in a nebulizer housing, not shown in the Figure.
  • a circumferential gap is arranged between the needle tip 42 and the inner wall of the conical part 40 of the sleeve, to allow the supplied air to reach aperture 39.
  • needle 37 is sealingly fixed in a holder 43, to which holder the outer sleeve 38 is also firmly and sealingly connected.
  • needle 37 is not fixed in the holder but is adjustably connected in the boring in the holder, e.g. by means of an adjusting screw, providing a sealed but adjustable connection.
  • the air supply 36 communicates with the interior of the outer sleeve through a hypodermic needle 44, sealingly fixed in a second boring in holder 43.
  • suitable glues can be used. However, instead of glues other connection means are suitable, such as screw and snap connections.
  • the inhalation means shown in Figure 4 comprises three chambers 25, 26 and 27 which communicate with each other by means of valves.
  • Chamber 25 communicates with the aerosol-drying chamber (16 in Figure 1)
  • chamber 26 is connected to a mouthpiece not shown in the drawing
  • chamber 27 is connected to filter 20 for the expired and surplus air.
  • Valve 28 between chambers 25 and 26 is kept pressed on valve seat 30 by means of a coil spring 29 with a spring force of approximately 8 mbar.
  • valve 28 is opened against the action of the spring 29, so that the aerosol can reach the mouthpiece through chamber 25 and 26.
  • the above-described aerosol generator-inhalator was used to atomise 0.5 ml of gold-195m eluate which comprised approximately 4% sodium thiosulphate in water in addition to a little radioactive gold.
  • the composition was atomised under the influence of dry compresses air which was supplied to the air inlet needle under a pressure of 400 kPa in a quantity of 2.75 litres per minute; the extra supplied drying air was 7.25 litres per minute so that the overall air supply was 10 litres per minute. After exactly 0.5 minute the composition was atomised completely.
  • the distribution of the particle size of the dried aerosol was measured in the mouthpiece of the inhalation means; the geometrically average volume diameter of the particles was 1.5 micrometers.
  • an aerosol was produced from 0.5 ml of a solution containing 50% ethanol and 50% water in which NaCl was dissolved at a concentration of 0.9 grams per liter.
  • the volume of 0.5 ml solution was nebulized in less than 3 minutes and resulted in dry aerosol in which the volume of the generated particles was distributed so that - measured with a laser aerosol sizing instrument - 50% of the volume consisted of particles below 0.9 micrometers diameter.
  • an aerosol was produced from 0.5 ml of a solution containing 100 micrograms of ruthenocene in 1 ml of ethanol 96%. This volume of 0.5 ml was nebulized in less than 3 minutes and did result in a dry particles aerosol with a distribution of the generated particles such that 50% of the volume of the dry particles consisted of particles below 0.3 micrometers diameter.
  • An aerosol was generated by means of the above described aerosol generator-inhalator, wherein the nebulizer of Figure 3 was installed, by nebulizing 0.5 ml of a radioactive complex of technetium-99m and N-[N'-(2,6-dimethylphenyl)carbamoylmethyl]imidiacetic acid (HIDA) in a solution equal to the solution described in Example II.
  • HIDA N-[N'-(2,6-dimethylphenyl)carbamoylmethyl]imidiacetic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP85200830A 1984-05-28 1985-05-23 Inhaliergerät mit einem Aerosolgenerator Expired EP0166476B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT85200830T ATE42685T1 (de) 1984-05-28 1985-05-23 Inhaliergeraet mit einem aerosolgenerator.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8401699 1984-05-28
NL8401699 1984-05-28

Publications (3)

Publication Number Publication Date
EP0166476A2 true EP0166476A2 (de) 1986-01-02
EP0166476A3 EP0166476A3 (en) 1986-04-02
EP0166476B1 EP0166476B1 (de) 1989-05-03

Family

ID=19844012

Family Applications (1)

Application Number Title Priority Date Filing Date
EP85200830A Expired EP0166476B1 (de) 1984-05-28 1985-05-23 Inhaliergerät mit einem Aerosolgenerator

Country Status (3)

Country Link
EP (1) EP0166476B1 (de)
AT (1) ATE42685T1 (de)
DE (1) DE3569880D1 (de)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0377174A2 (de) * 1988-12-22 1990-07-11 Büsselmann, Manfred Verfahren und Vorrichtung zum Zerstäuben und Vernebeln von flüssigen Stoffen
EP0641570A1 (de) * 1991-05-24 1995-03-08 Joseph G. Glenn Vernebler
GB2294401A (en) * 1994-10-26 1996-05-01 Ritzau Pari Werk Gmbh Paul Apparatus for generating an exact dose of aerosol
WO2000045878A3 (de) * 1999-02-03 2000-09-28 Max Delbrueck Centrum Druckluftinhalator zur pulmonalen applikation liposomalen pulver-aerosols sowie dafür geeignete pulver-aerosole
US7025058B2 (en) 2001-04-26 2006-04-11 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
EP2878327A4 (de) * 2012-07-24 2015-06-17 Korea Res Inst Chem Tech Vorrichtung zur inhalation von arzneimitteln
US9713516B2 (en) 2013-08-20 2017-07-25 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US9913952B2 (en) 2013-08-20 2018-03-13 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US10046124B2 (en) 2013-08-20 2018-08-14 Boehringer Ingelheim Vetmedica Gmbh Inhaler
IT202000019873A1 (it) * 2020-08-10 2022-02-10 Tommaso Giacalone Dispositivo di erogazione e cartuccia per prodotti da inalare

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63806C (de) * 1900-01-01
FR498215A (fr) * 1919-02-03 1920-01-06 Artur Duffek Dispositif pour inhalations
US2201701A (en) * 1938-08-27 1940-05-21 Carl E Newstrom Wall inset ironing table
US2535844A (en) * 1946-08-01 1950-12-26 John H Emerson Aspirator for administering medicine
FR1036384A (fr) * 1951-04-26 1953-09-07 Pulvérisateur réglable amélioré
US2868198A (en) * 1956-03-09 1959-01-13 Brooke Burnham Unidirectional valve for anesthesia equipment
FR86888E (fr) * 1962-10-25 1966-04-29 Perfectionnements aux appareils de respiration artificielle
FR2136920A1 (de) * 1971-05-07 1972-12-29 Smith Gisele
DE2722701A1 (de) * 1977-05-16 1978-11-23 Schering Ag Vorrichtung zur inhalations- bronchographie
FR2440742A1 (fr) * 1978-11-09 1980-06-06 Heyer Gmbh Inhalationstechnik Procede et dispositif de production d'un aerosol tempere
WO1980001645A1 (en) * 1979-02-12 1980-08-21 Hovmand E Respiratory valve face mask structure
US4268460A (en) * 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
DE3025936A1 (de) * 1980-07-09 1982-01-21 Wilhelm Hilzinger Gmbh & Co, 7000 Stuttgart Inhaliergeraet
WO1983003976A1 (en) * 1982-05-12 1983-11-24 Key Pharmaceuticals, Inc. Device and method for delivery of a drug

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL63806C (de) * 1900-01-01
FR498215A (fr) * 1919-02-03 1920-01-06 Artur Duffek Dispositif pour inhalations
US2201701A (en) * 1938-08-27 1940-05-21 Carl E Newstrom Wall inset ironing table
US2535844A (en) * 1946-08-01 1950-12-26 John H Emerson Aspirator for administering medicine
FR1036384A (fr) * 1951-04-26 1953-09-07 Pulvérisateur réglable amélioré
US2868198A (en) * 1956-03-09 1959-01-13 Brooke Burnham Unidirectional valve for anesthesia equipment
FR86888E (fr) * 1962-10-25 1966-04-29 Perfectionnements aux appareils de respiration artificielle
FR2136920A1 (de) * 1971-05-07 1972-12-29 Smith Gisele
DE2722701A1 (de) * 1977-05-16 1978-11-23 Schering Ag Vorrichtung zur inhalations- bronchographie
US4268460A (en) * 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
FR2440742A1 (fr) * 1978-11-09 1980-06-06 Heyer Gmbh Inhalationstechnik Procede et dispositif de production d'un aerosol tempere
WO1980001645A1 (en) * 1979-02-12 1980-08-21 Hovmand E Respiratory valve face mask structure
DE3025936A1 (de) * 1980-07-09 1982-01-21 Wilhelm Hilzinger Gmbh & Co, 7000 Stuttgart Inhaliergeraet
WO1983003976A1 (en) * 1982-05-12 1983-11-24 Key Pharmaceuticals, Inc. Device and method for delivery of a drug

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANN. OCCUP. HYG., vol. 19, 1976, pages 363-366; Pergamon Press, GB. P. KOTRAPPA et al.: "The performance of nebuliser and air ejector made from sections of hypodermic needles." * Whole article * *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0377174A2 (de) * 1988-12-22 1990-07-11 Büsselmann, Manfred Verfahren und Vorrichtung zum Zerstäuben und Vernebeln von flüssigen Stoffen
EP0377174A3 (de) * 1988-12-22 1990-11-22 Büsselmann, Manfred Verfahren und Vorrichtung zum Zerstäuben und Vernebeln von flüssigen Stoffen
EP0641570A1 (de) * 1991-05-24 1995-03-08 Joseph G. Glenn Vernebler
GB2294401A (en) * 1994-10-26 1996-05-01 Ritzau Pari Werk Gmbh Paul Apparatus for generating an exact dose of aerosol
GB2294401B (en) * 1994-10-26 1998-08-05 Ritzau Pari Werk Gmbh Paul Generation of an aerosol of an exact dose
WO2000045878A3 (de) * 1999-02-03 2000-09-28 Max Delbrueck Centrum Druckluftinhalator zur pulmonalen applikation liposomalen pulver-aerosols sowie dafür geeignete pulver-aerosole
US7025058B2 (en) 2001-04-26 2006-04-11 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
EP2878327A4 (de) * 2012-07-24 2015-06-17 Korea Res Inst Chem Tech Vorrichtung zur inhalation von arzneimitteln
US9713516B2 (en) 2013-08-20 2017-07-25 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US9913952B2 (en) 2013-08-20 2018-03-13 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US10046124B2 (en) 2013-08-20 2018-08-14 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US10737046B2 (en) 2013-08-20 2020-08-11 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US10869975B2 (en) 2013-08-20 2020-12-22 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US11679212B2 (en) 2013-08-20 2023-06-20 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US11964102B2 (en) 2013-08-20 2024-04-23 Boehringer Ingelheim Vetmedica Gmbh Inhaler
IT202000019873A1 (it) * 2020-08-10 2022-02-10 Tommaso Giacalone Dispositivo di erogazione e cartuccia per prodotti da inalare
WO2022034431A1 (en) * 2020-08-10 2022-02-17 Giacalone Tommaso Delivery device and cartridge for products to be inhaled

Also Published As

Publication number Publication date
DE3569880D1 (de) 1989-06-08
EP0166476A3 (en) 1986-04-02
ATE42685T1 (de) 1989-05-15
EP0166476B1 (de) 1989-05-03

Similar Documents

Publication Publication Date Title
JP4929282B2 (ja) セルフシールのｔ字部品および弁付きｔ字部品
EP1868570B1 (de) Systeme zum bedienen eines aerosol-erzeugers
JPS5923815B2 (ja) 噴霧器
JP4766745B2 (ja) 経鼻式吸入器
US5267555A (en) Apparatus and method for ionizing medication containing mists
CN109562237B (zh) 雾化喷嘴和操作这样的雾化喷嘴的方法
US20050196345A1 (en) Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols
JPH08502904A (ja) 低流量ネブライザ、噴霧化方法及び装置
JPH07504344A (ja) 粉末薬噴霧装置と噴霧方法
SK10942001A3 (sk) Inhalátor na stlačený vzduch na pulmonálnu aplikáciu lipozomálnych práškových aerosólov, ako aj iných práškových aerosólov vhodných na tento účel
EP0166476B1 (de) Inhaliergerät mit einem Aerosolgenerator
US6230703B1 (en) Aerosol inhalation device providing improved aerosol delivery
JP2023011484A (ja) 高速薬剤送達のための医療用噴霧器
CN113876748A (zh) 一种用于治疗肺动脉高压的曲前列尼尔气溶胶吸入剂的雾化方法
WO2023125466A1 (zh) 一种雾化触发结构及其雾化器
HUT76861A (en) An aerosol product and method for producing those
Hsiao et al. A Novel Contact-Triggered Vibrating-Mesh Nebulizer: Aerodynamic Performance and Drug Distribution of Suspension Drug Delivered with MicroBase μSMI
CN219614615U (zh) 一种雾化治疗装置
JPH11502440A (ja) 改良されたネブライザ及び該ネブライザを内蔵する吸入装置
CN211327626U (zh) 一种可分离药物的雾化面罩
WO2006108557A1 (en) Dry nebulizer
Unno et al. Deposition of sprayed particles in the nasal cavity
JPS6371048U (de)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LI NL SE

17P Request for examination filed

Effective date: 19860610

17Q First examination report despatched

Effective date: 19870904

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB IT LI NL SE

REF Corresponds to:

Ref document number: 42685

Country of ref document: AT

Date of ref document: 19890515

Kind code of ref document: T

ITF It: translation for a ep patent filed
REF Corresponds to:

Ref document number: 3569880

Country of ref document: DE

Date of ref document: 19890608

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
ITTA It: last paid annual fee
EAL Se: european patent in force in sweden

Ref document number: 85200830.9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19990503

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19990504

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19990505

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19990517

Year of fee payment: 15

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000524

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000531

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000531

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000531

BERE Be: lapsed

Owner name: MALLINCKRODT INC.

Effective date: 20000531

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20000523

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

EUG Se: european patent has lapsed

Ref document number: 85200830.9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20030502

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20030513

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20030520

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20030626

Year of fee payment: 19

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041201

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050131

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20041201

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST